Transdermal application of glyceryltrinitrate
Rietbrock, N.
Deutsche Medizinische Wochenschrift 110(43): 1673-1674
1985
ISSN/ISBN: 0012-0472 PMID: 3930198 Document Number: 249274
Document emailed within 1 workday
Related Documents
Black, K.S.; Hewitt, C.W.; Chau, C.L.; Pizzo, L. 1988: Transdermal application of cyclosporine prolongs skin allograft survival Transplantation Proceedings 20(2 Suppl 2: 660-662Kramar, M.; Giersch, K.H.; Schneider, H.T. 1987: Transdermal therapy of stable angina pectoris. Comparison of 2 different transdermal systems Fortschritte der Medizin 105(17): 340-342
Dittrich, R.; Parker, L.; Rosen, J.B.; Shangold, G.; Creasy, G.W.; Fisher, A.C. 2002: Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study American Journal of Obstetrics and Gynecology 186(1): 15-20
Dittrich, R.; Parker, L.; Rosen, J.B.; Shangold, G.; Creasy, G.W.; Fisher, A.C. 2002: Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study American Journal of Obstetrics and Gynecology 186(1): 15-20
Höchel, J.; Schuett, B.; Ludwig, M.; Zurth, C. 2014: Implications of different application sites on the bioavailability of a transdermal contraceptive patch containing ethinyl estradiol and gestodene: an open-label, randomized, crossover study International Journal of Clinical Pharmacology and Therapeutics 52(10): 856-866
Setnikar, I.; Rovati, L.C.; Thebault, J.J.; Guillaume, M.; Mignot, A.; Renoux, A.; Gualano, V. 1997: Pharmacokinetics of estradiol and of estrone during application of three strengths of an estradiol transdermal patch with active matrix Arzneimittel-Forschung 47(7): 859-865
Ankarberg-Lindgren, C.; Elfving, M.; Wikland, K.A.; Norjavaara, E. 2001: Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls Journal of Clinical Endocrinology and Metabolism 86(7): 3039-3044
McGriff-Lee, N.J. 2002: Transdermal testosterone gel (Cellegy) Current Opinion in Investigational Drugs 3(11): 1629-1632
Friend, D.R. 1990: Transdermal delivery of contraceptives Critical Reviews in Therapeutic Drug Carrier Systems 7(2): 149-186
Niedner, R. 1988: Transdermal therapeutic systems (TTS) Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 39(12): 761-766
Friend, D.R. 1991: Transdermal delivery of levonorgestrel Medicinal Research Reviews 11(1): 49-80
Hamblin, J.E.; Martin, C.A. 1987: Transdermal patch poisoning Pediatrics 79(1): 161
Aiache, J.M. 1997: Transdermal therapeutic methods Annales de Cardiologie et d'Angeiologie 46(7): 441-449
Côté, D. 1993: Dosage of transdermal fentanyl Clinical Pharmacy 12(10): 718
Mutschler, E.; Langguth, P. 1987: Transdermal therapeutic systems Fortschritte der Medizin 105(29): 571-574
2006: Transdermal selegiline (Emsam) Medical Letter on Drugs and Therapeutics 48(1235): 41-42
Maxwell, T. 1999: Cost is not the only consideration for transdermal fentanyl Oncology Nursing Forum 26(3): 496; Author Reply 497
Morrow, T. 2004: Transdermal patches are more than skin deep Managed Care 13(4): 50-51
2006: Transdermal methylphenidate (Daytrana) for ADHD Medical Letter on Drugs and Therapeutics 48(1237): 49-51
Rahal, P.S.; Wright, R.A. 1995: Transdermal nicotine and gastroesophageal reflux American Journal of Gastroenterology 90(6): 919-921